AMOR MEDICAL INC

AMOR MEDICAL INC

Breakthrough

Medical

Technology

learn more

MOF and Current Treatment

Multiple Organ Failure (MOF)

MOF starts with one of the detoxification organ failure: kidney, liver, lung

Once started, there is no drug/therapy that can reverse the organ failure process

The Gold Standard to treat MOF is Organ Transplantation

The mortality rate of MOF remains high at around 50%-80%

Currently physicians replicate the failing organ function with organ support devices.

Two common issues of organ failure are poor toxin removal and exess body fluid

For critically ill patients the 28-day survival rate is only 10%.

Twenty eight days are short to wait for an organ match

What is AMOR?

Our Advanced Multi-Organ Replacement system (AMOR) is a lifeline for un-transplantable patients and a bridge for transplant candidates. This state of the art system supports multiple organs, including liver and kidney, with lung function to be added.

Why AMOR?

Russian Abstract Wireframe Elements Distorted Icosahedron Tessellation

Supports Multiple Organs

Supports live, kidney, with lung to be added soon

Russian Abstract Wireframe Elements Cloned Spheres

Maximum Efficiency and efficacy

Maximizing protein bound detoxification and body fluid removal

Russian Abstract Wireframe Elements Concentric Sound Wave

Easy to Use

Maintain blood pressure and operate easily without special training

Russian Abstract Wireframe Elements Checkered Planes

Low Cost

An order of magnitude less expensive than existing methods

Clinical Trial

A clinical study at UW Medicine was conducted with AMOR prototype which could support both liver and kidney functions. .

10 liver failure patients accompanied by MOF were selected. They have failed in all existing treatments.

Using AMOR, all 10 patients were improved. Their survival rate was increased from 10% to 80%.

Our team is composed of renouned medical scholars and reserchers from University of Washington, where the kidney dialysis technology was inventd. We also have expert technologists, entreprenuers as well as a student team with extensive startup experience. Our innovation is protected by provisional patents.